Specific Advanced Solid Tumors
Oncology·MeSH: Hereditary Sensory and Autonomic Neuropathies
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| ACR-2316 | Acrivon Therapeutics, Inc. (ACRV) |
Frequently asked questions
How many drugs are in development for Specific Advanced Solid Tumors?
BioSniper tracks 1 drug in development for Specific Advanced Solid Tumors across 1 company.
How many clinical trials target Specific Advanced Solid Tumors?
There are 1 clinical trial targeting Specific Advanced Solid Tumors tracked by BioSniper.
Deep-dive into Specific Advanced Solid Tumors
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis